Organigram’s C$561 Million Offer Fends Off Curaleaf’s Hostile Aurora Bid
Organigram’s roughly C$561 million cash-and-stock offer for Aurora Cannabis at C$7.80 a share is agreed, compared with Curaleaf’s unsolicited C$6.45 bid. The offer represents a 21% premium over Curaleaf’s bid.
Organigram's roughly C$561 million offer for Canadian cannabis company Aurora Cannabis fends off a hostile bid from rival Curaleaf, marking a new turn in Aurora's buyout saga. At C$7.80 a share, the agreed cash-and-stock deal offers a 21% premium over Curaleaf's unsolicited C$6.45 bid and a 93% pre…